A protease assay needs a signal that appears when a bond is cut. Two chemistries dominate: a reporter group released from the C-terminus, and a fluorophore-quencher pair separated by cleavage. They are not interchangeable, and choosing the wrong one is a common reason an assay reports nothing while the enzyme is working perfectly well.
The peptide is synthesized with AMC (7-amino-4-methylcoumarin), AFC or pNA attached through the C-terminal carbonyl. Held as an amide, the reporter is dark or colourless. When the protease hydrolyses that last bond, free reporter is liberated and the signal appears.
Familiar examples include Ac-DEVD-AMC for caspase-3 and caspase-7, Suc-LLVY-AMC for calpain and the proteasome, and MeOSuc-AAPV-AMC for human leukocyte and pancreatic elastase. The chemistry is simple and the intact amide is essentially non-fluorescent, so the background is low and cleavage gives a large increase in signal. AMC is excited at 342 nm, however, so these assays are subject to the same interference from UV-absorbing and autofluorescent sample components as any other short-wavelength reporter.2
The limitation is structural rather than practical. Because the reporter occupies the position immediately after the scissile bond, the substrate has no residues on the prime side — it cannot fill the S1′, S2′ or S3′ subsites. For an exopeptidase or a protease that reads mostly on the non-prime side, that is fine. For an endopeptidase that needs contacts on both sides of the cut, it is a serious handicap, and the subsite picture explains why.
Here a donor fluorophore and a quencher sit at opposite ends of an intact peptide.1,7 While the two are within roughly 10 to 100 Å of each other and their spectra overlap, energy transfer keeps the donor dark. Cleavage anywhere between them separates the pair, and the donor emission is restored.2
This format lets the substrate span both sides of the scissile bond, so the enzyme sees a sequence resembling a real protein site. It is the natural choice for matrix metalloproteinases, viral proteases and anything else that reads the prime side. Historically it came first: donor-acceptor substrates for the kinetic assay of hydrolases were reported in 1973,3 and peptide amides of 7-amino-4-methylcoumarin followed in 1976–1977.4,5
Excitation and emission maxima below are as tabulated by the supplier of the corresponding building blocks;2 published values for some dyes, EDANS in particular, vary with solvent and with the measuring laboratory, so an assay should be set up against the spectra of the actual conjugate rather than against a table.
| Fluorophore | Excitation / emission | Usual quencher | Notes |
|---|---|---|---|
| AMC | 342 / 441 nm | — (released) | Most plate readers are set around 360–380 nm excitation and 440–460 nm emission for AMC assays. |
| AFC | 382 / 480 nm | — (released) | Longer wavelength than AMC, useful when sample autofluorescence is a problem. |
| pNA | absorbance at 405 nm | — (released) | Chromogenic rather than fluorescent: far less sensitive, but readable on any plate reader and free of fluorescence-specific interference, though strongly coloured samples can still absorb at 405 nm. |
| Mca | 328 / 393 nm | Dnp | The standard MMP pairing. Stable to normal Fmoc synthesis conditions. |
| EDANS | 341 / 471 nm | Dabcyl | Dabcyl has no fluorescence of its own and overlaps EDANS emission well.2 The pairing was established in the first resonance-energy-transfer substrates for retroviral proteases and remains in wide use.6 |
| Dansyl | 335 / 526 nm | Dabsyl | Large Stokes shift; less common now. |
| 5-FAM, 5-TAMRA | 494 / 521, 547 / 574 nm | Proprietary dark quenchers | Longer wavelengths avoid the interference that affects UV-excited reporters in biological samples. |
Move to longer wavelengths when the sample is dirty. AMC and EDANS are excited in the UV, where cell lysates, serum and many small-molecule inhibitors absorb and fluoresce. The thirty-year trend in substrate design has been toward longer wavelengths for exactly this reason. If a screen shows apparent inhibition by numerous unrelated compounds, suspect optical interference before biology.
| Your situation | Format |
|---|---|
| Exopeptidase, or a protease that reads the non-prime side | Releasable AMC or AFC |
| Endopeptidase needing prime-side contacts (MMPs, viral proteases) | Internally quenched FRET |
| Crude lysate, serum, or coloured compounds | Longer-wavelength pair, or chromogenic pNA |
| No fluorescence plate reader available | pNA, read by absorbance at 405 nm |
| Screening a compound library | Longer wavelengths, plus a counter-screen for optical interference |
Please email your project details to sales@lifetein.com or use our online quotation form. We make AMC, AFC, pNA and internally quenched substrates to order, including matched control peptides.
Sequences supplied by customers are treated as confidential and are never disclosed or reused.
All LifeTein peptides are supplied for laboratory research use only. They are not for human or veterinary use, and not for diagnostic or therapeutic use.